Detalhe da pesquisa
1.
Clinical implications of SRSF2 mutations in AML patients undergoing allogeneic stem cell transplantation.
Am J Hematol
; 96(10): 1287-1294, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289154
2.
Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML.
Ann Hematol
; 99(10): 2417-2427, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32862286
3.
Outcome prediction by the knowledge bank approach in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation.
Am J Hematol
; 97(10): E382-E384, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35802783
4.
Clinical value of the measurable residual disease status within the ELN2017 risk groups in AML patients undergoing allogeneic stem cell transplantation.
Am J Hematol
; 96(7): E237-E239, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811773
5.
Clinical Implications of the FLT3-ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation.
Cancers (Basel)
; 15(4)2023 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36831653
6.
A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older.
Bone Marrow Transplant
; 58(1): 30-38, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36195769
7.
Impact of IDH1 and IDH2 mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation.
Blood Adv
; 7(3): 436-444, 2023 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35381077
8.
Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 newly diagnosed myeloma patients: a retrospective real-world study.
J Cancer Res Clin Oncol
; 149(7): 3739-3752, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35987926
9.
Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remission.
Blood Adv
; 6(15): 4570-4580, 2022 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35605254
10.
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation.
Blood Cancer J
; 12(12): 170, 2022 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529759
11.
ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation.
Bone Marrow Transplant
; 56(4): 936-945, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33208914
12.
Nutritional Status at Diagnosis and Pre-transplant Weight Loss Impact Outcomes of Acute Myeloid Leukemia Patients Following Allogeneic Stem Cell Transplantation.
Hemasphere
; 5(3): e532, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33615146
13.
Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Cancers (Basel)
; 13(22)2021 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34830834
14.
Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation.
Leukemia
; 38(1): 198-201, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37880479
15.
Quantifying NPM1 MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line?
Hemasphere
; 8(3): e55, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38501048
16.
Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation.
Bone Marrow Transplant
; 56(10): 2610-2612, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34267355
17.
Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation.
Blood Cancer J
; 11(4): 80, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33927190
18.
The diagnostic red blood cell distribution width as a prognostic factor in acute myeloid leukemia.
Blood Adv
; 5(24): 5584-5587, 2021 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670273
19.
Pharmaceuticals in the environment: an educational perspective.
Environ Sci Pollut Res Int
; 18(9): 1555-66, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21573924